sepsis

NIH gets behind new Feinstein Institute sepsis study

By GREGORY ZELLER // A five-year National Institutes of Health grant will pack the protein into a new Long Island sepsis study. Monowar Aziz, an assistant professor at the Manhasset-based Feinstein Institute for Medical Research, will apply the $1.68 million award to his work examining protein’s role in inflammation and injury in due to sepsis, a body-wide immune system reaction to infection. Sepsis is a sinister opponent, causing nearly half-a-million U.S. deaths annually and leaving…


Feinstein, TheraSource target sepsis, with NIH’s help

By GREGORY ZELLER // With a little help from the besieged National Institutes of Health, a pillar of Long Island-based scientific research and one of its shining biotech spinoffs are taking the fight to a modern-medicine scourge responsible for some 500,000 U.S. deaths each year. The Feinstein Institute for Medical Research, the R&D division of the Northwell Health system, and Manhasset-based TheraSource LLC, a circa-2004 biopharma spun out of the Feinstein Institute, announced this week…


Feinstein researchers nab major NIH awards

Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang, Feinstein’s chief scientific officer, will continue their groundbreaking research into bioelectronic medicine and sepsis, respectively, with help from the NIH’s Maximizing Investigators’ Research Awards program. Through the NIH’s National Institute of General Medical Sciences – which supports “basic research that increases understanding of biological processes…


Taking down the hospital’s biggest killer

By GREGORY ZELLER // A Northwell Health clinical study is targeting a notorious killer that preys on weakened hospital patients. By testing white blood cells and monitoring “expression biomarkers,” SeptiCyte – a proprietary technology of Seattle-based Immunexpress – aims to provide faster and more accurate diagnosis of sepsis, a common blood poisoning caused by disease-spreading microorganisms. Pulmonary specialist Mangala Narasimhan, Northwell Health’s director of critical care, is leading a SeptiCyte human trial at North Shore…